Why is Bandaram Pharma falling/rising?

As of 14-Nov, Bandaram Pharma Packtech Ltd is experiencing a decline in its stock price, currently at 25.68, reflecting a decrease of 2.17, or 7.79%. The stock has shown significant underperformance today, falling after two consecutive days of gains, and opened with a loss of 4.81%. It reached an intraday low of Rs 24.26, marking a 12.89% drop. Over the past week, the stock has decreased by 3.96%, and its year-to-date return stands at a substantial decline of 42.16%. The company has a low Return on Capital Employed (ROCE) of 6.2, and despite a slight profit increase of 4% over the past year, the stock has underperformed the market significantly, with a one-year return of -40.58% compared to the BSE500's positive return of 8.00%.
In the broader market context, the stock's performance contrasts sharply with the benchmark, as it has underperformed the Sensex, which has gained 1.62% over the past week and 8.22% year-to-date. The stock's volatility has been high, with an intraday volatility of 5.97%, and a significant drop in investor participation, evidenced by a 96.18% decline in delivery volume compared to the five-day average. This lack of liquidity and the company's high Debt to EBITDA ratio of 6.31 times further contribute to the negative sentiment surrounding the stock, reinforcing its classification as a strong sell.